UBS Maintains Neutral on Corteva, Lowers Price Target to $85
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $89 to $85.
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $89 to $85.